Impact of Bulky & Liposomal Secukinumab on Lymphocytes of Psoriatic Patients, to Determine the Improvement in Bioavailability of Secukinumab Nanolipo. American Journal of Life Science and Innovation, [S. l.], v. 4, n. 1, p. 27–35, 2025. DOI: 10.54536/ajlsi.v4i1.3268. Disponível em: https://e-pallipublishers.com/index.php/ajlsi/article/view/3268. Acesso em: 17 apr. 2026.